359 related articles for article (PubMed ID: 12760799)
41. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
42. Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Fendri A; Masmoudi A; Khabir A; Sellami-Boudawara T; Daoud J; Frikha M; Ghorbel A; Gargouri A; Mokdad-Gargouri R
Cancer Biol Ther; 2009 Mar; 8(5):444-51. PubMed ID: 19221469
[TBL] [Abstract][Full Text] [Related]
43. IL-8 suppresses E-cadherin expression in nasopharyngeal carcinoma cells by enhancing E-cadherin promoter DNA methylation.
Zhang RL; Peng LX; Yang JP; Zheng LS; Xie P; Wang MY; Huang BJ; Zhao HR; Bao YX; Qian CN
Int J Oncol; 2016 Jan; 48(1):207-14. PubMed ID: 26530812
[TBL] [Abstract][Full Text] [Related]
44. Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma.
Ikeguchi M; Makino M; Kaibara N
J Surg Oncol; 2001 Jul; 77(3):201-7. PubMed ID: 11455558
[TBL] [Abstract][Full Text] [Related]
45. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Liu J; Ikeguchi M; Nakamura S; Kaibara N
J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
[TBL] [Abstract][Full Text] [Related]
46. [Correlation of E-cadherin, beta-catenin and gamma-catenin gene expression with the invasion and metastasis of gastric carcinoma].
Wang CX; Chen J; Yang Z; Song W; Du ZL; Li ZH
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1198-201. PubMed ID: 14625188
[TBL] [Abstract][Full Text] [Related]
47. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.
Garinis GA; Menounos PG; Spanakis NE; Papadopoulos K; Karavitis G; Parassi I; Christeli E; Patrinos GP; Manolis EN; Peros G
J Pathol; 2002 Dec; 198(4):442-9. PubMed ID: 12434413
[TBL] [Abstract][Full Text] [Related]
48. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
[TBL] [Abstract][Full Text] [Related]
49. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.
Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D
Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935
[TBL] [Abstract][Full Text] [Related]
50. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
51. Relation of E-cadherin and beta-catenin expression to pit pattern in colorectal cancer.
Kojima M; Shiokawa A; Ohike N; Tamegai Y; Kato H; Morohoshi T
Oncol Rep; 2004 Sep; 12(3):533-8. PubMed ID: 15289833
[TBL] [Abstract][Full Text] [Related]
52. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
[TBL] [Abstract][Full Text] [Related]
53. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC
Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928
[TBL] [Abstract][Full Text] [Related]
54. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
55. Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies.
Xu B; Sano T; Yoshimoto K; Yamada S
Endocr Pathol; 2002; 13(4):341-51. PubMed ID: 12665652
[TBL] [Abstract][Full Text] [Related]
56. Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma.
Yi B; Tan SX; Tang CE; Huang WG; Cheng AL; Li C; Zhang PF; Li MY; Li JL; Yi H; Peng F; Chen ZC; Xiao ZQ
J Cell Biochem; 2009 Apr; 106(5):858-66. PubMed ID: 19160382
[TBL] [Abstract][Full Text] [Related]
57. APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Kisters N; van Engeland M; Dunselman GA; de Haan J; de Goeij AF; Groothuis PG
Int J Gynecol Cancer; 2004; 14(5):947-56. PubMed ID: 15361208
[TBL] [Abstract][Full Text] [Related]
58. [Unusual expression and molecular mechanisms of E-cadherin, beta-catenin in correlation with clinicopathologic parameters in neuroblastoma].
Wu XR; Zhu MH; Zhang ZD; Yin MZ; Xi ZJ; Zhang FY; Zhang WZ
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):155-9. PubMed ID: 17535680
[TBL] [Abstract][Full Text] [Related]
59. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]